Biotechnology in Germany
Summary
Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications. Market value refers to the revenue generated from product sales, licensing fees, royalties, and research funding.
- The German biotechnology market recorded revenues of $15.7 billion in 2024, representing a compound annual growth rate (CAGR) of 23.9% between 2019 and 2024.
- The medical/healthcare segment accounted for the market's largest proportion in 2024, with total revenues of $14.4 billion, equivalent to 92.0% of the market's overall value.
- The German biotechnology market experienced unprecedented growth, fueled by a surge in equity financing and venture capital investments.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts
- What was the size of the Germany biotechnology market by value in 2024?
- What will be the size of the Germany biotechnology market in 2029?
- What factors are affecting the strength of competition in the Germany biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Germany's biotechnology market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the key players?
- 7.2. What strategies do the key players follow?
- 7.3. What have been the most recent market developments?
- 8 Company Profiles
- 8.1. Bayer AG
- 8.2. Boehringer Ingelheim International GmbH
- 8.3. BioNTech SE
- 8.4. Evotec SE
- 8.5. Merck KGaA
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Germany biotechnology industry value: $ million, 2019-24
- Table 2: Germany biotechnology industry category segmentation: % share, by value, 2019-24
- Table 3: Germany biotechnology industry category segmentation: $ million, 2019-24
- Table 4: Germany biotechnology industry geography segmentation: $ million, 2024
- Table 5: Germany biotechnology industry value forecast: $ million, 2024-29
- Table 6: Bayer AG: Key Facts
- Table 7: Bayer AG: Annual Financial Ratios
- Table 8: Bayer AG: Key Employees
- Table 9: Bayer AG: Key Employees Continued
- Table 10: Bayer AG: Key Employees Continued
- Table 11: Boehringer Ingelheim International GmbH: Key Facts
- Table 12: Boehringer Ingelheim International GmbH: Key Employees
- Table 13: BioNTech SE: Key Facts
- Table 14: BioNTech SE: Annual Financial Ratios
- Table 15: BioNTech SE: Key Employees
- Table 16: Evotec SE: Key Facts
- Table 17: Evotec SE: Annual Financial Ratios
- Table 18: Evotec SE: Key Employees
- Table 19: Merck KGaA: Key Facts
- Table 20: Merck KGaA: Annual Financial Ratios
- Table 21: Merck KGaA: Key Employees
- Table 22: Germany Size of Population (Million), 2019-24
- Table 23: Germany Real GDP (Constant 2010 Prices, $ Billion), 2019-24
- Table 24: Germany GDP (Current Prices, $ Billion), 2019-24
- Table 25: Germany Inflation, 2019-24
- Table 26: Germany Consumer Price Index (Absolute), 2019-24
- Table 27: Germany Exchange Rate, 2019-24
- List of Figures
- Figure 1: Germany biotechnology industry value: $ million, 2019-24
- Figure 2: Germany biotechnology industry category segmentation: $ million, 2019-24
- Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2024
- Figure 4: Germany biotechnology industry value forecast: $ million, 2024-29
- Figure 5: Forces driving competition in the biotechnology industry in Germany, 2024
- Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2024
- Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2024
- Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2024
- Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2024
- Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook